Home/Biolinq/Jared Tangney, PhD
JT

Jared Tangney, PhD

President & CTO

Biolinq

Biolinq Pipeline

DrugIndicationPhase
Biolinq Shine™ Autonomous Time-in-Range MicrosensorGlycemic control management in non-insulin using adults (22+)Approved
Multi-Analyte Platform DevelopmentMetabolic health / multiple biomarkers (Investigational)Pre-clinical